MC (C3)-Val-Cit-PAB-PNP CAS:1096584-62-1 is a small molecule drug that is composed of several functional groups. The C3 linker is a type of linker molecule that connects the drug molecule to a targeting moiety, allowing it to selectively bind to certain cells or tissues in the body. The Val-Cit dipeptide is a type of amino acid sequence that is commonly used as a cleavable linker in drug design. The PAB (p-aminobenzoic acid) group is a type of linker that is commonly used to attach the drug molecule to a targeting moiety, while the PNP (p-nitrophenyl) group is used as a chromophore to detect the presence of the drug in biological samples.
The combination of these functional groups in MC (C3)-Val-Cit-PAB-PNP is designed to create a drug that can be used to selectively target cancer cells in the body. The C3 linker, for example, can be used to attach the drug to a targeting moiety such as an antibody or peptide that can recognize and bind to cancer cells. The Val-Cit dipeptide can be used to release the drug once it has bound to the cancer cell, allowing it to exert its cytotoxic effects. Overall, MC (C3)-Val-Cit-PAB-PNP represents an important advance in the development of new drugs for the treatment of cancer and other diseases, and it holds significant promise for improving outcomes for patients in the future.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
